181 related articles for article (PubMed ID: 37819721)
21. Development of Allergic Conjunctivitis Induced by House Dust Mite Extract From Dermatophagoides pteronyssinus.
Lee YJ; Han SJ; Lee H; Kim JS; Seo KY
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1773-81. PubMed ID: 27074380
[TBL] [Abstract][Full Text] [Related]
22. Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis.
Bacsi A; Dharajiya N; Choudhury BK; Sur S; Boldogh I
J Allergy Clin Immunol; 2005 Oct; 116(4):836-43. PubMed ID: 16210058
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of mequitazine in comparison with placebo assessed by ocular challenge with allergen in allergic conjunctivitis.
Persi L; Dupin O; Arnaud B; Trinquand C; Michel FB; Bousquet J
Allergy; 1997 Apr; 52(4):451-4. PubMed ID: 9188930
[TBL] [Abstract][Full Text] [Related]
24. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
25. Effects of multiple dexamethasone treatments on aggravation of allergic conjunctivitis associated with mast cell hyperplasia.
Nagata T; Nabe T; Fujii M; Mizutani N; Kohno S
Biol Pharm Bull; 2008 Mar; 31(3):464-8. PubMed ID: 18310911
[TBL] [Abstract][Full Text] [Related]
26. Experimental Mouse Models of Ragweed- and Papain-Induced Allergic Conjunctivitis.
Matsuda A; Hirakata T; Asada Y; Nakae S
Methods Mol Biol; 2021; 2223():133-149. PubMed ID: 33226592
[TBL] [Abstract][Full Text] [Related]
27. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
[TBL] [Abstract][Full Text] [Related]
28. [Conjunctival provocation test].
Mortemousque B
J Fr Ophtalmol; 2007 Mar; 30(3):300-5. PubMed ID: 17417158
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.
Spangler DL; Abelson MB; Ober A; Gotnes PJ
Clin Ther; 2003 Aug; 25(8):2245-67. PubMed ID: 14512132
[TBL] [Abstract][Full Text] [Related]
30. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
Dake Y; Enomoto T; Cheng L; Enomoto K; Shibano A; Ikeda H; Yoda S; Yajin S; Sakota T; Yamanishi E
Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679
[TBL] [Abstract][Full Text] [Related]
31. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity.
Abelson MB; Spitalny L
Am J Ophthalmol; 1998 Jun; 125(6):797-804. PubMed ID: 9645717
[TBL] [Abstract][Full Text] [Related]
32. Multiple cedar pollen challenge diminishes involvement of histamine in allergic conjunctivitis of Guinea pigs.
Fukushima Y; Nabe T; Mizutani N; Nakata K; Kohno S
Biol Pharm Bull; 2003 Dec; 26(12):1696-700. PubMed ID: 14646173
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of specific immunotherapy in children with seasonal allergic rhinitis and conjunctivitis, sensitized to grass pollen].
Bulawa E; Borysewicz G; Markiewicz K; Derentowicz P
Med Wieku Rozwoj; 2001; 5(4):351-8. PubMed ID: 12004142
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial.
Fukushima A; Ebihara N
Adv Ther; 2014 Oct; 31(10):1045-58. PubMed ID: 25269854
[TBL] [Abstract][Full Text] [Related]
35. Effect of Mandarin Orange Yogurt on Allergic Conjunctivitis Induced by Conjunctival Allergen Challenge.
Hara Y; Shiraishi A; Sakane Y; Takezawa Y; Kamao T; Ohashi Y; Yasunaga S; Sugahara T
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2922-2929. PubMed ID: 28593244
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen-challenge model.
Brodsky M; Berger WE; Butrus S; Epstein AB; Irkec M
Eye Contact Lens; 2003 Apr; 29(2):113-6. PubMed ID: 12695716
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic and Therapeutic Effects of Oral Immunotherapy on Birch Pollen-Induced Allergic Conjunctivitis in Mice with a Rice-Based Edible Vaccine Expressing a Hypoallergenic Birch Pollen Allergen.
Ishida W; Kishimoto T; Takaiwa F; Fukuda K
Cells; 2021 Nov; 10(12):. PubMed ID: 34943868
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Alcaftadine 0.25% (AGN-229666) for Once-daily Prevention of Cedar-Pollen Allergic Conjunctivitis: A Phase 3 Randomized Study.
Fujishima H; Hasunuma T; Kawakita T; Sekiya T; Gomes P; Hollander DA
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1621-1626. PubMed ID: 32501774
[No Abstract] [Full Text] [Related]
40. Local allergic conjunctivitis: a phenotype of allergic conjunctivitis.
Yamana Y; Fukuda K; Ko R; Uchio E
Int Ophthalmol; 2019 Nov; 39(11):2539-2544. PubMed ID: 31093805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
